Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.73 |
| ▸ | CA1 | P00915 | 4/20 | 0.73 |
| ▸ | CA2 | P00918 | 4/20 | 0.73 |
| ▸ | CA9 | Q16790 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.63 |
| ▸ | HPGD | P15428 | 5/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.59 |
| ▸ | NSD2 | O96028 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.59 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.59 |
| ▸ | CASP6 | P55212 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL51034 | 1.00 | CA12 (0.73) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL1055674 | 1.00 | CA12 (0.73) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL1055673 | 0.98 | CA12 (0.71) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL1055670 | 0.98 | CA12 (0.71) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL69006 | 0.86 | CA12 (0.76) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL10423505 | 0.86 | ALDH1A1 (0.60) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL31080938 | 0.86 | CA12 (0.76) | CA12CA1CA2CA9ALDH1A1 | |
| Questiomycin B SCHEMBL1366115 | 0.86 | CA9 (0.60) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL1959737 | 0.85 | CA2 (1.00) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL31093944 | 0.84 | HPGD (0.68) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 673 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12403221-B2 | Preparation of composite gels, polymer scaffolds, aggregates and films comprising soluble cross-linked chitosan and uses thereof | NOVOCHIZOL SA (CH) | 2025-09-02 | — | — | US | claimed |
| EP-4103640-B1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | NOVOCHIZOL SA (CH) | 2025-02-26 | — | — | EP | claimed |
| US-20230096466-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | NOVOCHIZOL SA (CH) | 2023-03-30 | — | — | US | claimed |
| CN-115516012-A | Novel synthesis method and application of chitosan derivative | 诺和席卓股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| US-7723425-B2 | Pigment compositions with modified ATRP copolymer dispersants | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-05-25 | — | — | US | claimed |
| US-7678702-B2 | CMP composition of boron surface-modified abrasive and nitro-substituted sulfonic acid and method of use | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2010-03-16 | — | — | US | claimed |
| EP-0428534-B1 | COUPLING AGENTS AND STERICALLY HINDERED DISULFIDE LINKED CONJUGATES PREPARED THEREFROM | CETUS ONCOLOGY CORP (US) | 1995-03-29 | — | — | EP | claimed |
| CN-1083822-A | Polyoxymethylene-the ethylene oxide copolymer that is connected with biomolecules | AMGEN INC (US) | 1994-03-16 | — | — | CN | claimed |
| EP-0247860-B1 | TUMOR NECROSIS FACTOR FORMULATION AND ITS PREPARATION | CETUS ONCOLOGY CORPORATION (US) | 1992-07-08 | — | — | EP | claimed |
| CN-1051937-A | STEM CELL FACTOR | AMGEN INC (US) | 1991-06-05 | — | — | CN | claimed |
| EP-0428534-A1 | COUPLING AGENTS AND STERICALLY HINDERED DISULFIDE LINKED CONJUGATES PREPARED THEREFROM. | CETUS CORP (US) | 1991-05-29 | — | — | EP | claimed |
| WO-1989012624-A2 | COUPLING AGENTS AND STERICALLY HINDERED DISULFIDE LINKED CONJUGATES PREPARED THEREFROM | CETUS CORPORATION (US) | 1989-12-28 | — | — | WO | claimed |
| EP-0247860-A2 | Tumor necrosis factor formulation and its preparation | CETUS ONCOLOGY CORPORATION (US) | 1987-12-02 | — | — | EP | claimed |
| US-4487715-A | ACTIVATION, ESTERIFICATION, IMMOBILIZATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-12-11 | — | — | US | claimed |
| US-4483793-A | ANTIBODIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1984-11-20 | — | — | US | claimed |
| US-12403221-B2 | Preparation of composite gels, polymer scaffolds, aggregates and films comprising soluble cross-linked chitosan and uses thereof | NOVOCHIZOL SA (CH) | 2025-09-02 | — | — | US | disclosed |
| EP-4103640-B1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | NOVOCHIZOL SA (CH) | 2025-02-26 | — | — | EP | disclosed |
| US-4202698-A | DYE BLEACH CATALYSTS | CIBA-GEIGY AG (CH) | 1980-05-13 | — | — | US | disclosed |
| US-4145217-A | DYE BLEACH CATALYST | CIBA-GEIGY AG (CH) | 1979-03-20 | — | — | US | disclosed |
| US-3975196-A | Photoconductive charge transfer complex for electrophotography | PITNEY-BOWES, INC. (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096466-A1 | NEW METHOD OF SYNTHESIS OF CHITOSAN DERIVATIVES AND USES THEREOF | CHIA, CHIT1, CHI3L2 | CA12 77/4885CA1 551/4885CA2 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.